Clinical Trial Update: Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period [Phase 3]

View source ↗

Summary

This Phase 3 safety and efficacy trial of zoledronic acid for Paget's disease of bone has completed, including an extended observation period; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paget Disease of Bone

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paget's Disease of Bone | Phase 3 | Status: COMPLETED | Results posted: 2012-05-07